Myriad Genetics Inc operates in the Diagnostic substances sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Myriad Genetics Inc with three other
companies in this sector in the United States:
Amag Pharmaceuticals Incorporation
sales of $532.09 million
of which 100%
was License fees),
Meridian Bioscience, Inc.
of which 74%
was US Diagnostics), and
of which 55%
was Animal Safety).
Myriad Genetics Inc reported sales of $753.80 million
June of 2016.
increase of 4.2%
versus 2015, when the company's sales were $723.10 million.
Despite this increase, sales are still
below the level achieved in 2014, when Myriad Genetics Inc
reported sales of $778.22 million.
Sales of Others saw an increase
that was more than double the company's growth rate: sales were up
74.3% in 2016, from
$27.60 million to $48.10 million.